Wei‐Hsun Hsu
National Taiwan University(TW)National Taiwan University Hospital(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer therapeutics and mechanisms, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction
Most-Cited Works
- → CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential(2019)194 cited
- → Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3(2024)167 cited
- → Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations(2017)102 cited
- → Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors(2019)90 cited
- → Determination of clenbuterol in urine using headspace solid phase microextraction or liquid–liquid–liquid microextraction(2005)57 cited
- → Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death(2019)56 cited
- → Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan(2018)56 cited
- → Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non–Small-Cell Lung Cancer(2014)44 cited
- → The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia(2017)42 cited
- → The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population(2016)41 cited